메뉴 건너뛰기




Volumn 4, Issue 1, 1998, Pages 67-77

Antimicrobial resistant Streptococcus pneumoniae infections: Clinical and epidemiological trends

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN; IMIPENEM; LINCOSAMIDE; MACROLIDE; MEROPENEM; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

EID: 0032454802     PISSN: 1201026X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (3)
  • 1
    • 0030048691 scopus 로고    scopus 로고
    • Trends in infectious diseases mortality in the United States
    • Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 275: 189-193; 1996.
    • (1996) JAMA , vol.275 , pp. 189-193
    • Pinner, R.W.1    Teutsch, S.M.2    Simonsen, L.3
  • 2
    • 0026705492 scopus 로고
    • Epidemiology of drug resistance: Implications for a post-antimicrobial era (and others)
    • Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era (and others). Science 257: 1050-1082; 1992.
    • (1992) Science , vol.257 , pp. 1050-1082
    • Cohen, M.L.1
  • 3
    • 0031809434 scopus 로고    scopus 로고
    • Antibiotic resistance - What can we do?
    • Bax RP, Anderson R, Crew J, et al. Antibiotic resistance - what can we do? Nature Medicine 4: 545-546; 1998.
    • (1998) Nature Medicine , vol.4 , pp. 545-546
    • Bax, R.P.1    Anderson, R.2    Crew, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.